{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:08:12Z","timestamp":1767650892443},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.amjopharm.2008.11.002","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T15:36:14Z","timestamp":1232552174000},"page":"264-268","source":"Crossref","is-referenced-by-count":15,"title":["An elderly patient with fluoroquinolone-associated achilles tendinitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Emily","family":"Damuth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Heidelbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti N.","family":"Malani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro K.","family":"Cinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2008.11.002_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00002512-200320040-00005","article-title":"Fluoroquinolones in the elderly: Safety considerations","volume":"20","author":"Stahlmann","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.1999.00016.x","article-title":"Achilles tendinitis associated with fluoroquinolones","volume":"48","author":"van der Linden","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00002018-200629100-00006","article-title":"Evidence of tendinitis provoked by fluoroquinolone treatment: A casecontrol study","volume":"29","author":"Corrao","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib4_1","unstructured":"US Food and Drug Administration (FDA). FDA News. FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs: Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture [FDA Web site]."},{"key":"10.1016\/j.amjopharm.2008.11.002_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/ard.40.4.416","article-title":"Spontaneous rupture of the Achilles tendon in a patient with gout","volume":"40","author":"Mahoney","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/375078","article-title":"Fluoroquinolone-associated tendinopathy: A critical review of the literature","volume":"36","author":"Khaliq","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1440-1673.2005.01470.x","article-title":"Achilles tendinopathy after treatment with fluoroquinolone","volume":"49","author":"Yu","year":"2005","journal-title":"Australas Radiol"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1529-0131(200106)45:3<235::AID-ART254>3.0.CO;2-7","article-title":"Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998","volume":"45","author":"van der Linden","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/rheumatology\/37.3.343","article-title":"Fluoroquinolones as a cause of tendon disorders in patients with renal failure\/renal transplants","volume":"37","author":"Marti","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkg081","article-title":"Spontaneous Achilles tendon rupture in patients treated with levofloxacin","volume":"51","author":"Haddow","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1345\/aph.1C505","article-title":"Levofloxacin-associated Achilles tendon rupture","volume":"37","author":"Mathis","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.mop.0000192520.48411.fa","article-title":"The use of fluoroquinolones in children","volume":"18","author":"Leibovitz","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2006-1722","article-title":"The use of systemic fluoroquinolones","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib14","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1136\/emj.2006.035832","article-title":"Tendinitis: The Achilles heel of quinolones!","volume":"23","author":"Shortt","year":"2006","journal-title":"Emerg Med J"},{"key":"10.1016\/j.amjopharm.2008.11.002_bib15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.transproceed.2007.01.077","article-title":"Fluoroquinolones-induced tendonitis and tendon rupture in kidney transplant recipients: 2 Cases and a review of the literature","volume":"39","author":"Muzi","year":"2007","journal-title":"Transplant Proc"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T04:52:24Z","timestamp":1632977544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594608000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1543594608000718"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2008.11.002","relation":{},"ISSN":["1543-5946"],"issn-type":[{"type":"print","value":"1543-5946"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}